KEAP1 mutations as key crucial prognostic biomarkers for resistance to KRAS-G12C inhibitors
KEAP1 突变是 KRAS-G12C 抑制剂耐药性的关键预后生物标志物
期刊:Journal of Translational Medicine
影响因子:6.1
doi:10.1186/s12967-025-06089-y
Linyan Tian #, Chengming Liu #, Sufei Zheng, Huiyang Shi, Fang Wei, Wenxin Jiang, Yucheng Dong, Haiyan Xu, Enzhi Yin, Nan Sun, Jie He, Yan Wang